Skip to main content

Guardant Health

Guardant Health Inc is a precision oncology company headquartered in Palo Alto, California. The company develops non-invasive liquid biopsy tests, proprietary bioinformatic platforms, and diagnostic assays for cancer detection. Its primary commercial products include blood tests used for advanced cancer profiling, therapy selection, and recurrence monitoring. Revenue is derived from clinical test volume fees billed to insurance providers alongside biopharmaceutical research collaboration agreements. The company serves oncologists, research institutions, and pharmaceutical enterprises across global oncology markets. Guardant Health Inc is publicly traded on the Nasdaq Global Select Market.

20 of the funds FundTelligence covers report a position in Guardant Health.

Legal name
GUARDANT HEALTH INC
Sector
Health Care
Country
United States
Funds holding it
20
Exposure themes
Liquid Biopsy, Molecular Diagnostics, Precision Medicine & Genomics

Funds holding Guardant Health

Showing the 8 largest of 20 funds holding it.

Loading...